1 Product identity
Ingredient risk
1 ingredient to use with caution
Acidophilus & Bifidus
BrandVitaCeutical Labs→Non-Nutrient/Non-Botanical Capsule 9 ingredients 1 caution DSLD #53748Net contents: 100 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2015-11-24
2 Ingredients (9)
IngredientGroupSafety
BlendBlend—
Capsulecapsule—
CelluloseCellulose—
MaltodextrinMaltodextrin—
DextroseGlucose—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Lactobacillus — Limited Evidence
⚠ Rare sepsis if immunocompromised
⚠ Gas initially
Bifidobacterium — Limited Evidence
⚠ Gas initially
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID53748
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2015-11-24
6 More from VitaCeutical Labs
View VitaCeutical Labs Safety Scorecard → 180 products
100% Organic Flax Oil100% Organic Spirulina 500 mg5-HTP 100 mgAcetyl L-Carnitine 500 mgAcidophilusAdvanced Antioxidant Complex7 Cite this page
Vancouver
Pkhakadze G. Acidophilus & Bifidus — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 24]. Available from: https://supplement.ge/products/acidophilus-bifidus-53748/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG